Human apolipoprotein A-IV is a newly described plasma glycoprotein of intestinal origin, with several distinct and unusual properties. Although its metabolic function is unknown at present, preliminary studies indicate that it may play an important role in the intestinal absorption of lipids and the intravascular interaction of trigly-ceride-rich particles and HDL. It is the purpose of this work to examine the structural characteristics and in vitro lipid binding properties of human apo A-IV to gain insight into its biologic behavior. The structure and conformation of apo A-IV will be examined by fluorescence and CD spectropscopy under a variety of experimental conditions. The lipid associating properties of apo A-IV will be studied in vitro using well characterized particles of a phospholipid-triglyceride emulsion (TRP) as model chylomicrons. Factors which influence the affinity of apo A-IV for these particles will be determined. The influence of other purified plasma apoproteins on the interaction of apo A-IV and TRP will be examined to investigate the mechanism by which apo A-IV is displaced from the surface of these particles. Finally, the factors influencing the affinity of apo A-IV for human HDL will be examined in vitro, with regard for the increased affinity of apo A-IV for the abnormal lipoproteins found in certain human diseases. The significance of these proposed studies is that they will develop new knowledge of the structural and biophysical properties of this poorly studied apoprotein. The long range goal of this investigation is the elucidation of the role of intestinal apoproteins in the modulation of lipoprotein metabolism, and in the process of artherosclerosis.

Agency
National Institute of Health (NIH)
Institute
National Heart, Lung, and Blood Institute (NHLBI)
Type
Research Project (R01)
Project #
2R01HL030897-04
Application #
3341889
Study Section
Metabolism Study Section (MET)
Project Start
1984-06-01
Project End
1992-05-31
Budget Start
1987-06-01
Budget End
1988-05-31
Support Year
4
Fiscal Year
1987
Total Cost
Indirect Cost
Name
University of Texas Health Science Center Houston
Department
Type
Schools of Medicine
DUNS #
City
Houston
State
TX
Country
United States
Zip Code
77225
McKimmie, Ryan L; Easter, Linda; Weinberg, Richard B (2013) Acyl chain length, saturation, and hydrophobicity modulate the efficiency of dietary fatty acid absorption in adult humans. Am J Physiol Gastrointest Liver Physiol 305:G620-7
VerHague, Melissa A; Cheng, Dongmei; Weinberg, Richard B et al. (2013) Apolipoprotein A-IV expression in mouse liver enhances triglyceride secretion and reduces hepatic lipid content by promoting very low density lipoprotein particle expansion. Arterioscler Thromb Vasc Biol 33:2501-8
Weinberg, Richard B; Gallagher, James W; Fabritius, Melissa A et al. (2012) ApoA-IV modulates the secretory trafficking of apoB and the size of triglyceride-rich lipoproteins. J Lipid Res 53:736-43
Simon, Trang; Cook, Victoria R; Rao, Anuradha et al. (2011) Impact of murine intestinal apolipoprotein A-IV expression on regional lipid absorption, gene expression, and growth. J Lipid Res 52:1984-94
Blade, Anna M; Fabritius, Melissa A; Hou, Li et al. (2011) Biogenesis of apolipoprotein A-V and its impact on VLDL triglyceride secretion. J Lipid Res 52:237-44
Weinberg, Richard B; Cook, Victoria R (2010) Distinctive structure and interfacial activity of the human apolipoprotein A-IV 347S isoprotein. J Lipid Res 51:2664-71
Ledford, Aubrey S; Cook, Victoria A; Shelness, Gregory S et al. (2009) Structural and dynamic interfacial properties of the lipoprotein initiating domain of apolipoprotein B. J Lipid Res 50:108-15
Wong, Wai-Man R; Gerry, Andrew B; Putt, Wendy et al. (2007) Common variants of apolipoprotein A-IV differ in their ability to inhibit low density lipoprotein oxidation. Atherosclerosis 192:266-74
Beckstead, Jennifer A; Wong, Kasuen; Gupta, Vinita et al. (2007) The C terminus of apolipoprotein A-V modulates lipid-binding activity. J Biol Chem 282:15484-9
Weinberg, R B (1994) Identification of functional domains in the plasma apolipoproteins by analysis of inter-species sequence variability. J Lipid Res 35:2212-22

Showing the most recent 10 out of 11 publications